← Leaderboards
Debra L Ellies
Osteogenex, Inc
$1,625,963
Attributed
$1,625,963
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $556.4K · FY2006–13$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$1,625,963 · 3
By mechanism
R44$1,016,983 · 1
R43$608,980 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Clearance”
- Sharon A Nachman · Johns Hopkins University$212,600,639
- Nevan J Krogan · University Of California, San Francisco$67,452,049
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$60,104,394
- Xinhua Li · Nano Terra, Inc.$36,275,012
- Robert A Rissman · University Of California Irvine$24,784,138
- Kristine Yaffe · American Federation For Aging Research$21,969,486
Research focus
Drug ClearanceDrug Delivery SystemsAffectDoseAdverse EffectsBinding (Molecular Function)AnalogBiochemicalAnimalsDosageAwardAgreementBone DensityBone DiseasesBone LossBinding ProteinsBone ResorptionBone StrengthBoxingBiological AvailabilityBiomechanicsDatabasesDepositionDrug Development
Grant awards (4)
Oral delivered bone building therapy for osteoporosis$475,076
R43 · FY2013 · AR · contact PI
Anabolic Therapeutics for Increasing Bone Denisty and Quality$556,396
R44 · FY2009 · AR · contact PI
Anabolic Therapeutics for Increasing Bone Denisty and Quality$460,587
R44 · FY2008 · AR · contact PI
Therapeutics for increasing Bone Density and Quality$133,904
R43 · FY2006 · AR · contact PI